Javier Szwarcberg

Algemeen Directeur bij SPRUCE BIOSCIENCES, INC.

Vermogen: 1 M $ op 30-06-2026

56 jaar

Health Technology

Consumer Services

Profiel

Javier Szwarcberg is Chief Executive Officer & Executive Director at Spruce Biosciences, Inc. since 2022.
Formerly, Dr. Szwarcberg was Group VP, Head-Product & Portfolio Development at BioMarin Pharmaceutical, Inc. from 2020 to 2022, Senior VP-Program & Portfolio Management at Ultragenyx Pharmaceutical, Inc. from 2017 to 2020, and Vice President-Clinical & Business Development at Horizon Therapeutics Ltd. (Ireland) from 2016 to 2017.
Education includes a doctorate from Universidad de Buenos Aires and graduate studies at Harvard T.H.
Chan School of Public Health.

Bekende belangen in openbare bedrijven

Onderneming	Datum	Aantal aandelen	Totale waarde	Waarderingsdatum
SPRUCE BIOSCIENCES, INC. 1,8%	30-06-2026	19.270 ( 1,8% )	1 M $	30-06-2026

Actieve functies van Javier Szwarcberg

Bedrijven	Functie	Begin
SPRUCE BIOSCIENCES, INC.	Algemeen Directeur	03-01-2022

Alle actieve functies van Javier Szwarcberg

Eerdere bekende functies van Javier Szwarcberg

Bedrijven	Functie	Einde
BIOMARIN PHARMACEUTICAL INC.	Corporate Officer/Principal	01-01-2022
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	01-02-2020
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY	Hoofd Techniek/Wetenschap/O&O	01-10-2017

Ervaring van Javier Szwarcberg in detail bekijken

Opleiding van Javier Szwarcberg

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Javier Szwarcberg in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	6
BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions	Health Technology
Ultragenyx Pharmaceutical, Inc. Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases	Health Technology
Horizon Therapeutics Ltd. (Ireland) Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases	Health Technology
Universidad de Buenos Aires Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard T.H. Chan School of Public Health Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Spruce Biosciences, Inc. Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases	Health Technology